A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction

被引:482
作者
Freyman, T
Polin, G
Osman, H
Crary, J
Lu, MM
Cheng, L
Palasis, M
Wilensky, RL
机构
[1] Univ Penn, Hosp Univ Penn, Med Ctr, Div Cardiovasc, Philadelphia, PA 19104 USA
[2] Boston Sci Corp, Natick, MA USA
关键词
intracoronary; intravenous; endocardial; bone marrow derived stem cell; regeneration;
D O I
10.1093/eurheartj/ehi818
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Mesenchymal stem cells (MSCs), rare bone marrow-derived stem cell precursors of non-haematopoietic tissues, have shown promise in potentially repairing infarcted myocardium. These and similar cell types are being tested clinically, but understanding of delivery and subsequent biodistribution is lacking. This study was designed to quantitatively compare MSC engraftment rates after intravenous (IV), intracoronary (IC), or endocardial (EC) delivery in a porcine myocardial infarction (MI) model. Methods and results Allogeneic, male MSCs were cultured from porcine bone marrow aspirates. Iridium nanoparticles were added during culturing and internalized by the MSCs. An MI was induced in female swine (27-40 kg in size) by prolonged balloon occlusion of the mid-left anterior descending artery. Animals (n=6 per group) were randomized to one of three delivery methods. Cellular engraftment was determined 14 +/- 3 days post-delivery by measuring ex-vivo the iridium nanoparticle concentration in the infarct. Confirmation of cellular engraftment utilized both DiI and fluorescence in situ hybridization (FISH) labelling techniques. During MSC infusion, no adverse events were noted. However, following IC infusion, half of the pigs exhibited decreased blood flow distal to the infusion site. At 14 days, the mean number of engrafted cells within the infarct zone was significantly greater (P <= 0.01) following IC infusion than either EC injection or IV infusion and EC engraftment was greater than IV engraftment (P <= 0.01). There was less systemic delivery to the lungs following [EC vs. IV (P=0.02), EC vs. IC (P=0.06)]. Both DiI and FISH labelling demonstrated the presence of engrafted male MSCs within the female infarcted tissue. Conclusion IC and EC injection of MSCs post-MI resulted in increased engraftment within infarcted tissue when compared with IV infusion, and IC was more efficient than EC. However, IC delivery was also associated with a higher incidence of decreased coronary blood flow. EC delivery into acutely infarcted myocardial tissue was safe and well tolerated and was associated with decreased remote organ engraftment with compared with IC and IV deliveries.
引用
收藏
页码:1114 / 1122
页数:9
相关论文
共 31 条
[1]   Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury [J].
Abbott, JD ;
Huang, Y ;
Liu, D ;
Hickey, R ;
Krause, DS ;
Giordano, FJ .
CIRCULATION, 2004, 110 (21) :3300-3305
[2]   Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].
Askari, AT ;
Unzek, S ;
Popovic, ZB ;
Goldman, CK ;
Forudi, F ;
Kiedrowski, M ;
Rovner, A ;
Ellis, SG ;
Thomas, JD ;
DiCorleto, PE ;
Topol, EJ ;
Penn, MS .
LANCET, 2003, 362 (9385) :697-703
[3]   Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI) [J].
Assmus, B ;
Schächinger, V ;
Teupe, C ;
Britten, M ;
Lehmann, R ;
Döbert, N ;
Grünwald, F ;
Aicher, A ;
Urbich, C ;
Martin, H ;
Hoelzer, D ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2002, 106 (24) :3009-3017
[4]   Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].
Barbash, IM ;
Chouraqui, P ;
Baron, J ;
Feinberg, MS ;
Etzion, S ;
Tessone, A ;
Miller, L ;
Guetta, E ;
Zipori, D ;
Kedes, LH ;
Kloner, RA ;
Leor, J .
CIRCULATION, 2003, 108 (07) :863-868
[5]   Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction [J].
Chen, SL ;
Fang, W ;
Ye, F ;
Liu, YH ;
Qian, J ;
Shan, S ;
Zhang, J ;
Zhao, RCH ;
Liao, LM ;
Lin, S ;
Sun, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01) :92-95
[6]   In vivo tracking of stem cells for clinical trials in cardiovascular disease [J].
Frangioni, JV ;
Hajjar, RJ .
CIRCULATION, 2004, 110 (21) :3378-3383
[7]   Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells [J].
Hinds, KA ;
Hill, JM ;
Shapiro, EM ;
Laukkanen, MO ;
Silva, AC ;
Combs, CA ;
Varney, TR ;
Balaban, RS ;
Koretsky, AP ;
Dunbar, CE .
BLOOD, 2003, 102 (03) :867-872
[8]   Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone [J].
Horwitz, EM ;
Gordon, PL ;
Koo, WKK ;
Marx, JC ;
Neel, MD ;
McNall, RY ;
Muul, L ;
Hofmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8932-8937
[9]   A new methodology of mesenchymal stem cell expansion using magnetic nanoparticles [J].
Ito, A ;
Hibino, E ;
Honda, H ;
Hata, K ;
Kagami, H ;
Ueda, M ;
Kobayashi, T .
BIOCHEMICAL ENGINEERING JOURNAL, 2004, 20 (2-3) :119-125
[10]   Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial [J].
Kang, HJ ;
Kim, HS ;
Zhang, SY ;
Park, KW ;
Cho, HJ ;
Koo, BK ;
Kim, YJ ;
Lee, DS ;
Sohn, DW ;
Han, KS ;
Oh, BH ;
Lee, MM ;
Park, YB .
LANCET, 2004, 363 (9411) :751-756